SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 or 15d-16
UNDER THE SECURITIES EXCHANGE ACT of 1934
For the Month of August 2021
(Commission File Number)
P.V NANO CELL LTD.
(Translation of registrant’s name into English)
Migdal Ha’Emek, 2310102, Israel
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(l): _________
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): _________
P.V. Nano Cell Ltd. (the “Company”) hereby furnishes the following documents:
|i.||Notice and Proxy Statement with respect ot the Company’s annual general meeting of the shareholders to be held on September 19, 2021.|
|ii.||Proxy Card to be used with respect to the Company’s annual general meeting of the shareoldres to be held on September 19, 2021|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|Date: August 11, 2021||P.V NANO CELL LTD.|
|By:||/s/ Evyatar Cohen|
|Title:||Chief Financial Officer|